Xeno-free · Defined · Translational
Xeno-Free, Plant-Synthetic Biomaterials for Organoid Research, Translational Medicine, and Regenerative Innovation

Academia-Industry collaboration

Provide professional solutions and services to customers with diverse needs

  • Scientific Research and Translational Research Clients
    Scientific Research and Translational Research Clients
    We serve universities, hospitals, research institutes, CROs, and pharmaceutical R&D teams, offering comprehensive support for organoid culture, 3D cell model development, drug sensitivity testing, and mechanistic research.
  • Partners and Channel Customers
    Partners and Channel Customers
    We provide differentiated products and opportunities for joint development to overseas distributors, research reagent distributors, academic collaborators, and partners across the biomaterials industry.

Key Solutions

Powered by the HycopGel core product platform, we provide one-stop organoid solutions, including organoid biobanks, end-to-end reagents, integrated R&D and pharmaceutical services, and a wide range of organoid chips, supporting basic research and accelerating drug development.
  • HycopGel: An Engineered Hydrogel System
    HycopGel: An Engineered Hydrogel System
    A Core Material Platform for 3D Cell Culture and Organoid Engineering.
  • Organoid Culture Reagents and Workflow Solutions
    Organoid Culture Reagents and Workflow Solutions
    Providing culture media, auxiliary reagents, recovery solutions, and end-to-end support.
  • Tumor Organoid Drug Sensitivity Testing and Research Services
    Tumor Organoid Drug Sensitivity Testing and Research Services
    Supporting drug sensitivity testing using patient-derived samples and facilitating research collaborations.
  • Organoid Biobank and Chip Platform Expansion
    Organoid Biobank and Chip Platform Expansion
    Expanding a comprehensive organoid research ecosystem.
  • Core Features

    Precisely tunable physicochemical properties accurately recapitulate native tissue microenvironments. Combined with superior biocompatibility and lot-to-lot consistency, it effectively minimizes experimental variability.

    Tumor organoids
    Tumor organoids
    3D Cell Culture
    3D Cell Culture
    Drug Screening and Drug Sensitivity Assessment
    Drug Screening and Drug Sensitivity Assessment
    Tumor Xenograft Models
    Tumor Xenograft Models
    Invasion Assays
    Invasion Assays
    Regenerative Medicine and Tissue Engineering Research
    Regenerative Medicine and Tissue Engineering Research

    Data and Case Support

    We demonstrate the feasibility and stability of our products in scientific research applications through multi-cancer organoid culture data, pathological and immune characterization, drug sensitivity datasets, and comprehensive application case studies.
    Multi-Cancer-Type Organoid Culture Cases
    Multi-Cancer-Type Organoid Culture Cases
    As a precisely engineered hydrogel scaffold, HycopGel accurately recapitulates the in vivo microenvironment, empowering the construction of diverse tumor and organoid models.
    Morphology and Growth Performance vs. Conventional Matrigel Control
    Morphology and Growth Performance vs. Conventional Matrigel Control
    Comparative data show that HycopGel supports organoid morphology and growth performance identically to traditional Matrigel, while ensuring full compatibility with all downstream pathological assays.
    Support for Drug Susceptibility Assays and Downstream Analytical Workflows
    Support for Drug Susceptibility Assays and Downstream Analytical Workflows
    Comparative data demonstrate that cancer organoids cultured in HycopGel exhibit improved consistency and stability in drug sensitivity testing.
    Multi-Cancer-Type Organoid Culture Cases
    Multi-Cancer-Type Organoid Culture Cases
    Morphology and Growth Performance vs. Conventional Matrigel Control
    Morphology and Growth Performance vs. Conventional Matrigel Control
    Support for Drug Susceptibility Assays and Downstream Analytical Workflows
    Support for Drug Susceptibility Assays and Downstream Analytical Workflows

    A More Controllable, Stable, and Future-Oriented Material Direction

    COOP is committed to developing engineered biomaterials derived from non-animal sources, enhancing batch-to-batch consistency, ease of use, and research reproducibility, while driving future biomedical innovation through more sustainable technological approaches.
    • Animal-Free (Non-Animal-Derived)
    • Batch-to-Batch Consistency
    • Ease of Use
    • Long-Term Sustainability
    A More Controllable, Stable, and Future-Oriented Material Direction

    Seeking Global Partners

    Partner with COOP. We welcome global distributors, academic collaborators, and industry leaders to connect with us and jointly drive the future of organoid culture, 3D cell research, and biomaterials innovation.